» Articles » PMID: 29520159

Therapeutic Management of Classic Lichen Planopilaris: a Systematic Review

Overview
Publisher Dove Medical Press
Specialty Dermatology
Date 2018 Mar 10
PMID 29520159
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Several treatment strategies have been proposed in classic lichen planopilaris (LPP), although no gold standard therapeutic approach has been recognized so far due to the variable and, sometimes, contradictory results reported in the literature, as well as due to the lack of guidelines and randomized controlled trials. In the present review, we sought to provide an updated overview on the treatment of classic LPP by analyzing the level of evidence of published studies, also proposing a possible therapeutic strategy according to the findings highlighted in this systematic review.

Citing Articles

Multifaceted lichen planus: Vulvovaginal-gingival syndrome with coexisting cutaneous, nail, and hair manifestations in a singular clinical saga.

Rajenesh A, Gupta S, Chopra D Indian J Sex Transm Dis AIDS. 2025; 45(2):131-133.

PMID: 39886232 PMC: 11776909. DOI: 10.4103/ijstd.ijstd_113_23.


Increased expression of psoriasin (S100A7) and interleukin 17 (IL-17) in lesional skin in lichen planopilaris.

Otlewska-Szpotowicz A, Baran W, Wozniak Z, Szepietowski J, Batycka-Baran A Postepy Dermatol Alergol. 2024; 41(4):364-371.

PMID: 39290897 PMC: 11404093. DOI: 10.5114/ada.2024.142179.


Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany.

Stege H, Haist M, Schultheis M, Pawlowski J, Wittmann M, Grabbe S J Clin Med. 2024; 13(16).

PMID: 39201087 PMC: 11355652. DOI: 10.3390/jcm13164947.


Pruritus in Lichen Planopilaris and Frontal Fibrosing Alopecia-Clinical Characteristics and Dermoscopic Correlations.

Kolcz K, Krawczyk-Woloszyn K, Reich A, Zychowska M J Clin Med. 2024; 13(16).

PMID: 39201040 PMC: 11355708. DOI: 10.3390/jcm13164898.


Use of Hydroxychloroquine in Hair Disorders.

Ravipati A, Randolph M, Al-Salhi W, Tosti A Skin Appendage Disord. 2023; 9(6):416-422.

PMID: 38058539 PMC: 10697765. DOI: 10.1159/000533583.


References
1.
Errichetti E, Stinco G . Dermoscopy in General Dermatology: A Practical Overview. Dermatol Ther (Heidelb). 2016; 6(4):471-507. PMC: 5120630. DOI: 10.1007/s13555-016-0141-6. View

2.
Spencer L, Hawryluk E, English 3rd J . Lichen planopilaris: retrospective study and stepwise therapeutic approach. Arch Dermatol. 2009; 145(3):333-4. DOI: 10.1001/archdermatol.2008.590. View

3.
Spring P, Spanou Z, de Viragh P . Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: lack of lasting improvement or cure in the majority of patients. J Am Acad Dermatol. 2013; 69(5):830-832. DOI: 10.1016/j.jaad.2013.04.066. View

4.
Jayasekera P, Walsh M, Hurrell D, Parslew R . Case Report of Lichen Planopilaris Occurring in a Pediatric Patient Receiving a Tumor Necrosis Factor α Inhibitor and a Review of the Literature. Pediatr Dermatol. 2016; 33(2):e143-6. DOI: 10.1111/pde.12768. View

5.
Mehregan D, Van Hale H, Muller S . Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol. 1992; 27(6 Pt 1):935-42. DOI: 10.1016/0190-9622(92)70290-v. View